Written question asked by Baroness Hollins (Crossbench) on Wednesday, 13 March 2024, in the House of Lords. It was due for an answer on Wednesday, 27 March 2024. It was answered by Lord Markham (Conservative) on Thursday, 21 March 2024 on behalf of the Department of Health and Social Care.
Coronavirus: Vaccination
- Question
-
To ask His Majesty's Government what progress they have made, if any, in reaching a settlement in cases of individuals who have developed (1) blood clots, and (2) life-changing conditions, such as transverse myelitis, after receiving the COVID-19 AstraZeneca vaccine; and what assessment they have made of the level of payment being awarded under the Vaccine Damage Payment scheme.
- Answer
-
The Government knows there are some extremely rare cases where individuals have sadly experienced harm following vaccination against COVID-19, and recognises how difficult this is for those individuals and their families. It would not be appropriate to comment on individual cases, including where there may be ongoing litigation that may involve the Government.
As part of business-as-usual work, the Government reviews the payment amount of the Vaccine Damage Payment Scheme (VDPS), alongside all routine policy on a regular basis. There are no plans at this time to change the level of payment awarded under the VDPS.
Secondary information
- Type
- Written question
- Reference
- HL3245
- Session
- 2023-24
- Subjects
- Vaccination Side effects AstraZeneca Vaccine damage payment scheme Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2024-03-21 15:37:09 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL3245
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL3245
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL3245